Stocks
Veracyte, Inc.VCYT
NASDAQHealthcareBiotechnology$32.13+3.88%
Specializing in genomic diagnostics, this company provides precision medicine solutions for cancer and other diseases through its proprietary testing platforms. Veracyte has established itself as a key player in molecular diagnostics, with investors monitoring its growth in the expanding market for non-invasive diagnostic tools. The firm's tests are used by clinicians to guide treatment decisions, reducing unnecessary procedures and healthcare costs.
Market Cap: $2.6B52W Range: $22.61 – $50.71
Congressional Interest in Veracyte, Inc. (VCYT)
3 members of Congress have disclosed 15 trades in Veracyte, Inc. (VCYT), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 7 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
15
Unique Politicians
3
Buys
8
Sells
7
Who in Congress Is Trading VCYT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-02-18 | Gilbert Cisneros | buy | $1K – $15K |